Antiangiogenic drugs as a novel anticancer therapeutic strategy - Which are the more promising agents? What are the clinical developments and indications?

被引:16
作者
Gasparini, G [1 ]
机构
[1] Azienda Osped Bianchi Melacrino Morelli, Div Oncol, I-89100 Reggio Calabria, Italy
关键词
D O I
10.1016/S1040-8428(97)10001-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:147 / 162
页数:16
相关论文
共 122 条
[21]   EXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) IN HUMAN NORMAL AND TUMOR-TISSUES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
BOCCIA, J ;
CASALS, D ;
BERTINO, JR ;
MELAMED, MR .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (09) :1277-1287
[22]   THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].
DAMATO, RJ ;
LOUGHNAN, MS ;
FLYNN, E ;
FOLKMAN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085
[23]   2-METHOXYESTRADIOL, AN ENDOGENOUS MAMMALIAN METABOLITE, INHIBITS TUBULIN POLYMERIZATION BY INTERACTING AT THE COLCHICINE SITE [J].
DAMATO, RJ ;
LIN, CM ;
FLYNN, E ;
FOLKMAN, J ;
HAMEL, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3964-3968
[24]   EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors [J].
deWit, R ;
Pawinsky, A ;
Stoter, G ;
vanOosterom, AT ;
Fossa, SD ;
Paridaens, R ;
Svedberg, A ;
deMulder, PHM .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (03) :493-495
[25]   MICROVASCULAR INJURY IN PATHOGENESIS OF INTERFERON-INDUCED NECROSIS OF SUBCUTANEOUS TUMORS IN MICE [J].
DVORAK, HF ;
GRESSER, I .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (07) :497-502
[26]  
DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
[27]   Development of angiogenesis inhibitors for cancer therapy [J].
Eckhardt, SG ;
Pluda, JM .
INVESTIGATIONAL NEW DRUGS, 1997, 15 (01) :1-3
[28]  
Eckhardt SG, 1996, ANN ONCOL, V7, P491
[29]  
ESEKOWITZ RA, 1992, NEW ENGL J MED, V326, P1456
[30]   Vascular endothelial growth factor [J].
Ferrara, N .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2413-2422